JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hartwell, B. L. Articles by Mark, J. B. Search for Related Content PubMed PubMed Citation Articles by Hartwell, B. L. Articles by Mark, J. B.

Combinations of ß-Blockers and Calcium Channel Blockers

A Cause of Malignant Perioperative Conduction Disturbances?

Received from the Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Abstract

Many patients are treated for angina pectoris with a combination of a calcium channel blocker and a ß-blocking agent. The safety and efficacy of such combination therapy are well-documented (1,2). When considering any modification of this drug regimen preoperatively, most anesthetists elect to continue all antianginal medications until the time of surgery. A recent editorial supports this view (3), and more important, the only prospective study published to date (4) provides a solid basis for this practice.

However, adverse effects have been reported with the use of such combinations, most commonly when verapamil is combined with a ß-blocker. Left ventricular dysfunction, bradyarrhythmias, complete heart block, hypotension, and death have all been described (5–7). Furthermore, we now are seeing patients treated with a three-drug regimen consisting of a ß-blocker plus two calcium channel blockers (nifedipine plus diltiazem or verapamil). The challenge is to anticipate which patients and which drug combinations present the greatest risk for perioperative hemodynamic problems.

We report a patient with coronary artery disease, chronically treated with nifedipine, diltiazem, and nadolol, who developed malignant bradyarrhythmias and hypotension during anesthetic induction. Hemodynamic restoration required aggressive pharmacologic treatment, including an isoproterenol infusion. The severe conduction problems seen in this patient and the pharmacologic treatment required may have contributed to the patient's early postoperative demise.

This article has been cited by other articles:

				V. Piriou, A. Aouifi, and J.J. Lehot Interet des beta-bloquants en medecine perioperatoire. Premiere partie: notions fondamentales Can J Anesth, July 1, 2000; 47(7): 653 - 663. [Abstract] [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999